These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 20392512

  • 21. Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome.
    Ezquer M, Ezquer F, Ricca M, Allers C, Conget P.
    J Hepatol; 2011 Nov; 55(5):1112-20. PubMed ID: 21356258
    [Abstract] [Full Text] [Related]

  • 22. Etiology of fatty liver in dairy cattle: effects of nutritional and hormonal status on hepatic microsomal triglyceride transfer protein.
    Bremmer DR, Trower SL, Bertics SJ, Besong SA, Bernabucci U, Grummer RR.
    J Dairy Sci; 2000 Oct; 83(10):2239-51. PubMed ID: 11049064
    [Abstract] [Full Text] [Related]

  • 23. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis.
    Mirandola S, Realdon S, Iqbal J, Gerotto M, Dal Pero F, Bortoletto G, Marcolongo M, Vario A, Datz C, Hussain MM, Alberti A.
    Gastroenterology; 2006 May; 130(6):1661-9. PubMed ID: 16697730
    [Abstract] [Full Text] [Related]

  • 24. Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis.
    Lo L, McLennan SV, Williams PF, Bonner J, Chowdhury S, McCaughan GW, Gorrell MD, Yue DK, Twigg SM.
    J Hepatol; 2011 Aug; 55(2):435-44. PubMed ID: 21184785
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF, Purushotham A, Wendel AA, Belury MA.
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Changes in hepatic microsomal triglyceride transfer protein and triglyceride in periparturient dairy cattle.
    Bremmer DR, Bertics SJ, Besong SA, Grummer RR.
    J Dairy Sci; 2000 Oct; 83(10):2252-60. PubMed ID: 11049065
    [Abstract] [Full Text] [Related]

  • 29. Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism.
    Musso G, Cassader M, De Michieli F, Rosina F, Orlandi F, Gambino R.
    Hepatology; 2012 Sep; 56(3):933-42. PubMed ID: 22684858
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Interstrain differences in susceptibility to non-alcoholic steatohepatitis.
    Yamazaki Y, Kakizaki S, Takizawa D, Ichikawa T, Sato K, Takagi H, Mori M.
    J Gastroenterol Hepatol; 2008 Feb; 23(2):276-82. PubMed ID: 17868334
    [Abstract] [Full Text] [Related]

  • 32. Oleate-mediated stimulation of microsomal triglyceride transfer protein (MTP) gene promoter: implications for hepatic MTP overexpression in insulin resistance.
    Qiu W, Taghibiglou C, Avramoglu RK, Van Iderstine SC, Naples M, Ashrafpour H, Mhapsekar S, Sato R, Adeli K.
    Biochemistry; 2005 Mar 01; 44(8):3041-9. PubMed ID: 15723548
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ, Yeh MM, Van Rooyen DM, Brooling J, Ghatora K, Farrell GC.
    J Gastroenterol Hepatol; 2012 Feb 01; 27(2):341-50. PubMed ID: 21929649
    [Abstract] [Full Text] [Related]

  • 36. Mechanisms underlying different responses of plasma triglyceride to high-fat diets in hamsters and mice: roles of hepatic MTP and triglyceride secretion.
    Gao S, He L, Ding Y, Liu G.
    Biochem Biophys Res Commun; 2010 Aug 06; 398(4):619-26. PubMed ID: 20510883
    [Abstract] [Full Text] [Related]

  • 37. Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development.
    Yang M, Liu Q, Huang T, Tan W, Qu L, Chen T, Pan H, Chen L, Liu J, Wong CW, Lu WW, Guan M.
    Theranostics; 2020 Aug 06; 10(24):10874-10891. PubMed ID: 33042259
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.